BioAdaptives
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioAdaptives generated cash of -$223,773, which is more than the previous year. Cash used in financing activities reached the amount of $259,144 last year. Net change in cash is therefore $35,371.
Cash Flow
| 2013 | -18.98K | 18.60K | 37.59K |
|---|---|---|---|
| 2014 | -58.62K | -1.58K | 79.47K |
| 2015 | -72 | 25.27K | -37.7K |
| 2017 | -540 | 0 | -6.73K |
| 2018 | -402.14K | 32K | 426K |
| 2019 | -168.12K | 3.21K | 124.21K |
| 2020 | -106.88K | 328 | 99.16K |
| 2021 | -158.65K | 254 | 237K |
| 2022 | -227.25K | 148 | 169.72K |
| 2023 | -223.77K | 0 | 259.14K |
BDPT Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 25.40K | 82.93K | 4.58K | 12.31K | 56.21K | 360 | 7.63K | 37.87K | 18.60K | -18.60K |
Operating activities | ||||||||||
Net income | -712.46K | -895.57K | -1.04M | -847.24K | -238.92K | -1.40M | -64.41K | -227.43K | -2.57M | -18.28K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 28.17K | 62.14K | 133.79K | 179.84K | 158.08K | 0 | 0 | 528 | 527 | 0 |
Stock-based compensation expense | 0 | 0 | 163.9K | 139.64K | 92.79K | 0 | 39.18K | 49.69K | 2.36M | 0 |
| Deferred income tax benefit | 0 | 0 | 163.9K | 139.64K | 92.79K | 0 | 39.18K | 49.69K | 2.36M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | -227.13K | -60.96K | -38.72K | 0 | 0 | 0 | 0 | 0 |
Inventories | -6.40K | -4.12K | 9.06K | -2.68K | 38.72K | -19.38K | 1.81K | 0 | 0 | 0 |
Accounts payable | 39.68K | 183.75K | 227.13K | 60.96K | -23.99K | 0 | -2.54K | 159.88K | 2.54K | 0 |
Cash generated by operating activities | -223.77K | -227.25K | -158.65K | -106.88K | -168.12K | -402.14K | -540 | -72 | -58.62K | -18.98K |
Investing activities | ||||||||||
Purchases Of Investments | 42 | 148 | 254 | 328 | 3.21K | 0 | 0 | 25.27K | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.58K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 148 | 254 | 328 | 3.21K | 32K | 0 | 25.27K | -1.58K | 18.60K |
Financing activities | ||||||||||
Common Stock Issued | 178.1K | 521.67K | 856.62K | 168.69K | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.75K |
Repayments of term debt | 80K | 169.72K | -20K | -18.35K | 67K | 0 | 0 | -35K | 0 | 0 |
Cash used in financing activities | 259.14K | 169.72K | 237K | 99.16K | 124.21K | 426K | -6.73K | -37.7K | 79.47K | 37.59K |
Net Change In Cash | 35.37K | -57.53K | 78.34K | -7.72K | -43.90K | 55.85K | -7.27K | -37.77K | 19.26K | 37.21K |
Cash at end of period | 60.77K | 25.40K | 82.93K | 4.58K | 12.31K | 56.21K | 360 | 99 | 37.87K | 18.61K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |